Replies to post #359737 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

What if a Big Crash...?

Barring market crash of 80-90% of value....

Yes, what if the ensuing recession, by the end of the summer, turns into a major crash? What then, Anavex? In that case, here’s the scenario I envision.

By the end of the summer, at least one of the three clinical trials of blarcamesine will have concluded and top line data released. Those data will be entirely positive, allowing and causing the FDA (or the Australian Therapeutic Goods Administration) to authorize sale and therapeutic use(s) of the drug. In that case, it’s very possible that Anavex Life Sciences Corp (AVXL) becomes a “safe haven” stock; a safe port in the stock price storm to park investment dollars during a declining or volatile share pricing interval. With any sort of positive clinical results, while stock markets slide, AVXL should be able to hold a good portion of its value. With the realization of ensuing corporate revenues, the share price should ascend.

As with all matters Anavex, the only thing that actually accounts will be Phase 3 clinical results; everything else is emotional jabber.